Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H4958

Introduced
1/28/26  

Caption

Relative to opioid use disorder treatment and rehabilitation coverage

Impact

The bill will significantly amend existing insurance laws in Massachusetts by introducing a clearer pathway to treatment for individuals grappling with opioid addiction. By eliminating costs associated with deductibles, coinsurance, and out-of-pocket limits for opioid-related treatments, the legislation aims to lessen the financial barriers that hinder individuals from seeking help. Additionally, provisions for coverage as both a medical and pharmacy benefit will standardize the way these treatments are reimbursed, encouraging healthcare facilities to provide necessary services without the threat of balance billing to patients. This legislation is poised to have a positive impact on public health, particularly in communities disproportionately affected by opioid addiction.

Summary

House Bill H4958 is an act aimed at improving the treatment and rehabilitation coverage for individuals suffering from opioid use disorder in Massachusetts. This bill mandates that coverage for prescribed or dispensed opioid antagonists and agonists, including partial agonists, be deemed medically necessary without requiring prior authorization. Furthermore, it stipulates that healthcare practitioners' prescriptions will not be necessary for such treatments, broadening access for patients in need of immediate care. The intent behind these provisions is to tackle the ongoing opioid epidemic by ensuring that therapeutic options are readily accessible to both active and retired employees covered under various health insurance plans.

Contention

Despite the well-meaning efforts of HB H4958, some critics may express concerns about the implications of mandating treatment coverage without prior authorization. There are arguments about the potential for increased costs to insurance providers and whether the lack of oversight could lead to over-prescription or misuse in some cases. Additionally, stakeholders may debate the role of prescriptions in ensuring that professionals are involved in the treatment process, which guarantees that medications are administered responsibly. However, supporters argue that removing such barriers significantly contributes to public health efforts aimed at combating the opioid crisis while promoting a more humane approach to treatment.

Companion Bills

MA H1337

Replaces Relative to opioid use disorder treatment and rehabilitation coverage

Previously Filed As

MA H1337

Relative to opioid use disorder treatment and rehabilitation coverage

MA HB2063

Relating To Opioid Use Disorder Treatment.

MA SB2505

Relating To Opioid Use Disorder Treatment.

MA HB718

Opioid use disorder; require substance use disorder facilities to provide pregnant women with onsite access to certain treatments.

MA H824

Expand Treatment Access/Opioid Use Disorder

MA SB00365

An Act Establishing A Bridge Program For Emergency Treatment And Recovery Navigation For Persons With An Opioid Use Disorder.

MA H4014

Authorizing pharmacists to provide opioid use disorder treatment

MA S1635

Authorizing pharmacists to provide opioid use disorder treatment

MA HB2528

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

MA HB683

AN ACT relating to coverage for the treatment of postpartum mood disorders.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

HI HB310

Relating To Opioid Antagonists.

TX HB4783

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

AZ HB2697

Expired opioid antagonists; use

MT SB503

Allow use of expired opioid antagonists

TX HB1103

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

MI SB0401

Health: pharmaceuticals; co-prescribing of naloxone with opioid drugs; require. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).

TX SB556

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.